Pulse lineResearch With Heart Logo

ARIC Publications

Journal Article
Wei P, Cao Y, Zhang Y, Xu Z, Kwak I-Y, Boerwinkle E. "On Robust Association Testing for Quantitative Traits and Rare Variants." G3 (Bethesda). 2016;6(12):3941-3950.
Kwong AM, Blackwell TW, LeFaive J, et al. "Robust, flexible, and scalable tests for Hardy-Weinberg equilibrium across diverse ancestries." Genetics. 2021;218(1).
Elbein SC, Wang X, Karim MA, et al. "Role of a proline insertion in the insulin promoter factor 1 (IPF1) gene in African Americans with type 2 diabetes." Diabetes. 2006;55(10):2909-14.
Kucharska-Newton AM, Monda KL, Bielinski SJ, et al. "Role of BMI in the Association of the TCF7L2 rs7903146 Variant with Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study." J Obes. 2010;2010.
Wang Z, Chen H, Bartz TM, et al. "Role of Rare and Low-Frequency Variants in Gene-Alcohol Interactions on Plasma Lipid Levels." Circ Genom Precis Med. 2020;13(4):e002772.
Houston DK, Stevens J, Cai J, Morey MC. "Role of weight history on functional limitations and disability in late adulthood: the ARIC study." Obes Res. 2005;13(10):1793-802.
E Estes H, Zhang Z-M, Li Y, Tereschenko LG. "The Romhilt-Estes left ventricular hypertrophy score and its components predict all-cause mortality in the general population." Am Heart J. 2015;170(1):104-9.
Wang W, Wang W, Mosley TH. "A SAS macro for the joint modeling of longitudinal outcomes and multiple competing risk dropouts." Comput Methods Programs Biomed. 2017;138:23-30.
Bijari PB, Antiga L, Wasserman BA, Steinman DA. "Scan-Rescan reproducibility of carotid bifurcation geometry from routine contrast-enhanced MR angiography." J Magn Reson Imaging. 2011;33(2):482-9.
"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe." Eur Heart J. 2021;42(25):2439-2454.
"SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions." Eur Heart J. 2021;42(25):2455-2467.
"Seasonal fibrinogen fluctuations among elderly people." Lancet. 1991;338(8767):629-30.
Gambin T, Jhangiani SN, Below JE, et al. "Secondary findings and carrier test frequencies in a large multiethnic sample." Genome Med. 2015;7(1):54.
Sanders AE, Slade GD, Beck JD, Agústsdóttir H. "Secondhand smoke and periodontal disease: atherosclerosis risk in communities study." Am J Public Health. 2011;101 Suppl 1:S339-46.
Toole JF, Lefkowitz DS, Chambless LE, Wijnberg L, Paton CC, Heiss G. "Self-reported transient ischemic attack and stroke symptoms: methods and baseline prevalence. The ARIC Study, 1987-1989." Am J Epidemiol. 1996;144(9):849-56.
Volcik KA, Catellier D, Folsom AR, Matijevic N, Wasserman B, Boerwinkle E. "SELP and SELPLG genetic variation is associated with cell surface measures of SELP and SELPLG: the Atherosclerosis Risk in Communities Carotid MRI Study." Clin Chem. 2009;55(6):1076-82.
Hyun N, Couper DJ, Zeng D. "A semiparametric Gumbel regression model for analyzing longitudinal data with non-normal tails." Stat Med. 2022;41(4):736-750.
Wong KYau, Zeng D, Lin DY. "SEMIPARAMETRIC LATENT-CLASS MODELS FOR MULTIVARIATE LONGITUDINAL AND SURVIVAL DATA." Ann Stat. 2022;50(1):487-510.
Gao F, Zeng D, Couper DJ, Lin DY. "Semiparametric Regression Analysis of Multiple Right- and Interval-Censored Events." J Am Stat Assoc. 2019;114(527):1232-1240.
Stevens J, Couper D, Pankow J, et al. "Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort." Obes Res. 2001;9(11):696-705.
Ferket BS, van Kempen BJH, Wieberdink RG, et al. "Separate prediction of intracerebral hemorrhage and ischemic stroke." Neurology. 2014;82(20):1804-12.
Morrison AC, Bis JC, Hwang S-J, et al. "Sequence analysis of six blood pressure candidate regions in 4,178 individuals: the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) targeted sequencing study." PLoS One. 2014;9(10):e109155.
Wu B, Pankow JS. "Sequence Kernel Association Analysis of Rare Variant Set Based on the Marginal Regression Model for Binary Traits." Genet Epidemiol. 2015;39(6):399-405.
Wu B. "Sequence Kernel Association Test of Multiple Continuous Phenotypes." Genet Epidemiol. 2016;40(2):91-100.
Folsom AR, Peacock JM, Boerwinkle E. "Sequence variation in proprotein convertase subtilisin/kexin type 9 serine protease gene, low LDL cholesterol, and cancer incidence." Cancer Epidemiol Biomarkers Prev. 2007;16(11):2455-8.
Bressler J, Franceschini N, Demerath EW, Mosley TH, Folsom AR. "Sequence variation in telomerase reverse transcriptase (TERT) as a determinant of risk of cardiovascular disease: the Atherosclerosis Risk in Communities (ARIC) study." BMC Med Genet. 2015;16:52.
Liu C-T, Young KL, Brody JA, et al. "Sequence variation in TMEM18 in association with body mass index: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study." Circ Cardiovasc Genet. 2014;7(3):344-9.
Cohen JC, Boerwinkle E, Mosley TH, Hobbs HH. "Sequence variations in PCSK9, low LDL, and protection against coronary heart disease." N Engl J Med. 2006;354(12):1264-72.
Feofanova EV, Yu B, Metcalf GA, et al. "Sequence-Based Analysis of Lipid-Related Metabolites in a Multiethnic Study." Genetics. 2018;209(2):607-616.
Liang J, Cade BE, He KY, et al. "Sequencing Analysis at 8p23 Identifies Multiple Rare Variants in DLC1 Associated with Sleep-Related Oxyhemoglobin Saturation Level." Am J Hum Genet. 2019;105(5):1057-1068.
Bis JC, White CC, Franceschini N, et al. "Sequencing of 2 subclinical atherosclerosis candidate regions in 3669 individuals: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study." Circ Cardiovasc Genet. 2014;7(3):359-64.
Taliun D, Harris DN, Kessler MD, et al. "Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program." Nature. 2021;590(7845):290-299.
Magnani JW, Brody JA, Prins BP, et al. "Sequencing of SCN5A identifies rare and common variants associated with cardiac conduction: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium." Circ Cardiovasc Genet. 2014;7(3):365-73.
Folsom AR, Roetker NS, Rosamond WD, Heckbert SR, Basu S, Cushman M. "Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study." J Thromb Haemost. 2014;12(9):1455-60.
Alonso A, Misialek JR, Michos ED, et al. "Serum 25-hydroxyvitamin D and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study." Europace. 2016;18(8):1143-9.
Zhang Y, Post WS, Dalal D, et al. "Serum 25-hydroxyvitamin D, calcium, phosphorus, and electrocardiographic QT interval duration: findings from NHANES III and ARIC." J Clin Endocrinol Metab. 2011;96(6):1873-82.
Millen AE, Nie J, Mares JA, et al. "Serum 25-Hydroxyvitamin D Concentrations and Incidence of Age-Related Macular Degeneration: The Atherosclerosis Risk in Communities Study." Invest Ophthalmol Vis Sci. 2019;60(5):1362-1371.
Shrestha S, Lutsey PL, Alonso A, Huang X, Mosley TH. "Serum 25-hydroxyvitamin D concentrations in Mid-adulthood and Parkinson's disease risk." Mov Disord. 2016;31(7):972-8.
Rapson IR, Michos ED, Alonso A, Hirsch AT, Matsushita K, Reis JP. "Serum 25-hydroxyvitamin D is associated with incident peripheral artery disease among white and black adults in the ARIC study cohort." Atherosclerosis. 2017;257:123-129.
Folsom AR, Lutsey PL, Heckbert SR, Cushman M. "Serum albumin and risk of venous thromboembolism." Thromb Haemost. 2010;104(1):100-4.
Shannon CM, Ballew SH, Daya N, et al. "Serum albumin and risks of hospitalization and death: Findings from the Atherosclerosis Risk in Communities study." J Am Geriatr Soc. 2021.
Nelson JJ, Liao D, Sharrett AR, et al. "Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study." Am J Epidemiol. 2000;151(5):468-77.
Misialek JR, Lopez FL, Lutsey PL, et al. "Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans--Atherosclerosis Risk in Communities (ARIC) study." Circ J. 2013;77(2):323-9.
Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. "Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study." Arch Intern Med. 1999;159(18):2151-9.
Chatterjee R, Yeh H-C, Shafi T, et al. "Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study." Arch Intern Med. 2010;170(19):1745-51.
Rooney MR, Pankow JS, Sibley SD, Selvin E, Reis JP, Michos ED. "Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study." Am J Clin Nutr. 2016;104(4):1023-1029.
Fyfe-Johnson AL, Alonso A, Selvin E, Bower JK, Pankow JS, Agarwal SK. "Serum fibroblast growth factor-23 and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study." J Hypertens. 2016;34(7):1266-72.
Rebholz CM, Grams ME, Coresh JJ, et al. "Serum fibroblast growth factor-23 is associated with incident kidney disease." J Am Soc Nephrol. 2015;26(1):192-200.
Tsai AW, Cushman M, Tsai MY, et al. "Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE)." Am J Hematol. 2003;72(3):192-200.
Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR. "Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study." Am J Epidemiol. 2002;156(4):349-52.
Carnethon MR, Palaniappan LP, Burchfiel CM, Brancati FL, Fortmann SP. "Serum insulin, obesity, and the incidence of type 2 diabetes in black and white adults: the atherosclerosis risk in communities study: 1987-1998." Diabetes Care. 2002;25(8):1358-64.
Rebholz CM, Grams ME, Chen Y, Gross AL, Sang Y, Coresh JJ. "Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease." Am J Epidemiol. 2017;186(8):952-960.
Rooney MR, Lutsey PL, Alonso A, et al. "Serum magnesium and burden of atrial and ventricular arrhythmias: The Atherosclerosis Risk in Communities (ARIC) Study." J Electrocardiol. 2020;62:20-25.
Larsson SC, Traylor M, Burgess S, Boncoraglio GB, Jern C, Michaëlsson K. "Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study." Neurology. 2019;92(9):e944-e950.
Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folsom AR. "Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study." Am Heart J. 2010;160(3):464-70.
Rooney MR, Alonso A, Folsom AR, et al. "Serum magnesium and the incidence of coronary artery disease over a median 27 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study and a meta-analysis." Am J Clin Nutr. 2020;111(1):52-60.
Menez S, Ding N, Grams ME, et al. "Serum magnesium, bone-mineral metabolism markers and their interactions with kidney function on subsequent risk of peripheral artery disease: the Atherosclerosis Risk in Communities Study." Nephrol Dial Transplant. 2020;35(11):1878-1885.
Lutsey PL, Alonso A, Michos ED, Loehr LR, Astor BC, Coresh JJ. "Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Clin Nutr. 2014;100(3):756-64.
Kim H, Hu EA, Wong KE, et al. "Serum Metabolites Associated with Healthy Diets in African Americans and European Americans." J Nutr. 2021;151(1):40-49.
Menni C, Zhu J, Le Roy CI, et al. "Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes." Gut Microbes. 2020;11(6):1632-1642.
Rebholz CM, Yu B, Zheng Z, et al. "Serum metabolomic profile of incident diabetes." Diabetologia. 2018;61(5):1046-1054.
Yu B, Zheng Y, Nettleton JA, Alexander D, Coresh JJ. "Serum metabolomic profiling and incident CKD among African Americans." Clin J Am Soc Nephrol. 2014;9(8):1410-7.
Kim H, Yu B, Li X, et al. "Serum metabolomic signatures of plant-based diets and incident chronic kidney disease." Am J Clin Nutr. 2022;116(1):151-164.
Alonso A, Yu B, Sun YV, et al. "Serum Metabolomics and Incidence of Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study)." Am J Cardiol. 2019;123(12):1955-1961.
Chatterjee R, Yeh H-C, Shafi T, et al. "Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Clin Nutr. 2011;93(5):1087-91.
Chen Y, Chang AR, McAdams DeMarco MA, et al. "Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study." Mayo Clin Proc. 2016;91(10):1403-1412.
Lindberg G, Iso H, Råstam L, Lundblad A, Folsom AR. "Serum sialic acid and its correlates in community samples from Akita, Japan and Minneapolis, USA." Int J Epidemiol. 1997;26(1):58-63.
Lindberg G, Råstam L, Nilsson-Ehle P, et al. "Serum sialic acid and sialoglycoproteins in asymptomatic carotid artery atherosclerosis. ARIC Investigators. Atherosclerosis Risk in Communities." Atherosclerosis. 1999;146(1):65-9.
Chen G-C, Chai JChoul, Yu B, et al. "Serum sphingolipids and incident diabetes in a US population with high diabetes burden: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)." Am J Clin Nutr. 2020;112(1):57-65.
Wang A, Barber JR, Tin A, De Marzo AM, Köttgen A, Joshu CE. "Serum Urate, Genetic Variation, and Prostate Cancer Risk: Atherosclerosis Risk in Communities (ARIC) Study." Cancer Epidemiol Biomarkers Prev. 2019;28(7):1259-1261.
Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. "Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study." Ann Epidemiol. 2000;10(3):136-43.
Hozawa A, Folsom AR, Ibrahim H, Nieto JF, Rosamond WD, Shahar E. "Serum uric acid and risk of ischemic stroke: the ARIC Study." Atherosclerosis. 2006;187(2):401-7.
Kubota Y, McAdams-DeMarco M. "Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study." Thromb Res. 2016;144:144-8.
Mellen PB, Bleyer AJ, Erlinger TP, et al. "Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study." Hypertension. 2006;48(6):1037-42.
Faridi KF, Zhao D, Martin SS, et al. "Serum vitamin D and change in lipid levels over 5 y: The Atherosclerosis Risk in Communities study." Nutrition. 2017;38:85-93.
Schneider ALC, Zhao D, Lutsey PL, et al. "Serum Vitamin D Concentrations and Cognitive Change Over 20 Years: The Atherosclerosis Risk in Communities Neurocognitive Study." Neuroepidemiology. 2018;51(3-4):131-137.
Lu J, Zaimi I, Barber JR, et al. "SES and correlated factors do not explain the association between periodontal disease, edentulism, and cancer risk." Ann Epidemiol. 2019;38:35-41.
Rost NS, Sadaghiani S, Biffi A, et al. "Setting a gold standard for quantification of leukoaraiosis burden in patients with ischemic stroke: the Atherosclerosis Risk in Communities Study." J Neurosci Methods. 2014;221:196-201.
Chambless LE, Cummiskey CP, Cui G. "Several methods to assess improvement in risk prediction models: extension to survival analysis." Stat Med. 2011;30(1):22-38.
Lee AK, Rawlings AM, Lee CJ, et al. "Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study." Diabetologia. 2018;61(9):1956-1965.

Pages